Skip to content

H.R. 6109 · 118th Congress (2023–2025)

PILLS Act

To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.

CRS summary not yet available.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 6109’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Claudia Tenney (R-NY-24)
Cosponsors
5 cosponsors

0 original · 5 later

  1. Rep. Nicole Malliotakis (R-NY-11)· Later · Nov 13, 2023
  2. Rep. Carol D. Miller (R-WV-1)· Later · Dec 12, 2023
  3. Rep. Gregory F. Murphy (R-NC-3)· Later · Dec 12, 2023
  4. Rep. W. Gregory Steube (R-FL-17)· Later · Dec 22, 2023
  5. Rep. Mike Kelly (R-PA-16)· Later · Jan 30, 2024
Policy area
Taxation

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Oct 26, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the House Committee on Ways and Means.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseWays and MeansReferred Oct 26, 2023
  2. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. PILLS Act

    Display title, Short title · Introduced in House

  2. Producing Incentives for Long-term production of Lifesaving Supply of Medicine Act

    Short title · Introduced in House

  3. To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.

    Official title · Introduced in House